AbstractThe global transcriptional profile of peripheral blood mononuclear cells (PBMCs) stimulated with HIV candidate vaccine (virus-like particles, VLPs) has been evaluated in HIV-infected patients with low/high viral load compared to healthy volunteers. Baseline activation of chemokine production was observed in PBMC from HIV-infected patients and innate immune stimulation with HIV-VLPs was not blunted. The immune profile among HIV-infected patients was found to be qualitatively similar but quantitatively extremely variable. This diversity was independent of viral load and it might be dependent on individual immunogenetic traits or concurrent immunological status.This ex vivo screening strategy represents an efficient tool for guiding mo...
Chronic inflammation and immune dysfunction play a key role in the development of non-AIDS–related c...
HIV-Controllers (HIC) maintain control of HIV replication without combined antiretroviral treatment ...
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtyp...
AbstractThe global transcriptional profile of peripheral blood mononuclear cells (PBMCs) stimulated ...
AbstractCultured primary peripheral blood mononuclear cells (PBMC) represent a potentially physiolog...
Introduction: An effective prophylactic vaccine against HIV will need to elicit antibody responses c...
We have investigated whether PBMC of HIV-1-seropositive subjects are as susceptible to in vitro infe...
HIV compromises the human immune system and establishes life long infection. While HIV can be effect...
The pox-protein regimen tested in the RV144 trial is the only vaccine strategy demonstrated to preve...
International audienceHIV controllers (HIC) maintain control of HIV replication without combined ant...
Infections of the human immunodeficiency virus (HIV) trigger host immune responses, but the virus ca...
AbstractHuman immunodeficiency virus type-1 (HIV-1) Pr55Gag virus-like particles (VLP) represent an ...
The underlying mechanism responsible for the development of broadly neutralizing antibodies (bNAbs) ...
The rare patients who spontaneously control HIV replication in the absence of therapy show signs of ...
International audienceUnderstanding the mechanism(s) by which broadly neutralizing antibodies (bNAbs...
Chronic inflammation and immune dysfunction play a key role in the development of non-AIDS–related c...
HIV-Controllers (HIC) maintain control of HIV replication without combined antiretroviral treatment ...
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtyp...
AbstractThe global transcriptional profile of peripheral blood mononuclear cells (PBMCs) stimulated ...
AbstractCultured primary peripheral blood mononuclear cells (PBMC) represent a potentially physiolog...
Introduction: An effective prophylactic vaccine against HIV will need to elicit antibody responses c...
We have investigated whether PBMC of HIV-1-seropositive subjects are as susceptible to in vitro infe...
HIV compromises the human immune system and establishes life long infection. While HIV can be effect...
The pox-protein regimen tested in the RV144 trial is the only vaccine strategy demonstrated to preve...
International audienceHIV controllers (HIC) maintain control of HIV replication without combined ant...
Infections of the human immunodeficiency virus (HIV) trigger host immune responses, but the virus ca...
AbstractHuman immunodeficiency virus type-1 (HIV-1) Pr55Gag virus-like particles (VLP) represent an ...
The underlying mechanism responsible for the development of broadly neutralizing antibodies (bNAbs) ...
The rare patients who spontaneously control HIV replication in the absence of therapy show signs of ...
International audienceUnderstanding the mechanism(s) by which broadly neutralizing antibodies (bNAbs...
Chronic inflammation and immune dysfunction play a key role in the development of non-AIDS–related c...
HIV-Controllers (HIC) maintain control of HIV replication without combined antiretroviral treatment ...
Several new human monoclonal antibodies (mAbs) with a neutralizing potential across different subtyp...